| RS1571416477 |
PBX1
|
Health Risk |
Pathogenic |
— |
| RS1571416623 |
PBX1
|
Health Risk |
Pathogenic |
— |
| RS1571418365 |
PPOX
|
Health Risk |
Likely pathogenic |
Variegate porphyria, Variegate porphyria |
| RS1571418855 |
TPM3
|
Health Risk |
Likely pathogenic |
Congenital myopathy 4B, autosomal recessive |
| RS1571427781 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS1571431063 |
PBX1
|
Health Risk |
Likely pathogenic |
Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears |
| RS1571431145 |
PBX1
|
Health Risk |
Pathogenic |
Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears |
| RS1571436535 |
SPTA1
|
Health Risk |
Likely pathogenic |
Hemolytic anemia, Hemolytic anemia |
| RS1571445295 |
PBX1
|
Health Risk |
Likely pathogenic |
Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears |
| RS1571456678 |
TPM3
|
Health Risk |
Likely pathogenic |
Congenital myopathy 4B, autosomal recessive |
| RS1571464589 |
POGZ
|
Health Risk |
Pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1571470447 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS1571488364 |
FLAD1
|
Health Risk |
Likely pathogenic |
— |
| RS1571522690 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 1, Retinitis pigmentosa 12 |
| RS1571523319 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 1, Leber congenital amaurosis 1 |
| RS1571523755 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1571524102 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 1, Leber congenital amaurosis 8 |
| RS1571524269 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1571524490 |
ST3GAL3
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1571525145 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 1, Leber congenital amaurosis 1 |
| RS1571525390 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1571530029 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS1571530070 |
SPTA1
|
Health Risk |
Likely pathogenic |
Pyropoikilocytosis, hereditary |
| RS1571531732 |
SLC19A2
|
Health Risk |
Pathogenic |
— |
| RS1571532822 |
SLC19A2
|
Health Risk |
Pathogenic |
Megaloblastic anemia, thiamine-responsive |
| RS1571533545 |
POGZ
|
Health Risk |
Pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1571535301 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS1571537544 |
SLC19A2
|
Health Risk |
Pathogenic |
Megaloblastic anemia, thiamine-responsive |
| RS1571537879 |
SLC19A2
|
Health Risk |
Pathogenic |
Megaloblastic anemia, thiamine-responsive |
| RS1571538391 |
LAMC2
|
Health Risk |
Likely pathogenic |
— |
| RS1571540037 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS1571540258 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Leber congenital amaurosis 8 |
| RS1571544281 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis |
| RS1571544334 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa 12 |
| RS1571557821 |
PKP1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex due to plakophilin deficiency, Epidermolysis bullosa simplex due to plakophilin deficiency |
| RS1571557864 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 1, Leber congenital amaurosis 8 |
| RS1571563202 |
PRG4
|
Health Risk |
Pathogenic |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
| RS1571563769 |
AP4B1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 47, Spastic paraplegia |
| RS1571564381 |
PKP1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex due to plakophilin deficiency, Epidermolysis bullosa simplex due to plakophilin deficiency |
| RS1571564812 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pigmented paravenous retinochoroidal atrophy, Retinitis pigmentosa 12 |
| RS1571569884 |
PRG4
|
Health Risk |
Pathogenic |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
| RS1571572235 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1571572316 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1571574574 |
F5
|
Health Risk |
Likely pathogenic |
Factor V deficiency, Factor V deficiency |
| RS1571575520 |
F5
|
Health Risk |
Pathogenic/Likely pathogenic |
Factor V deficiency, Congenital factor V deficiency |
| RS1571575523 |
PRG4
|
Health Risk |
Pathogenic |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
| RS1571577365 |
F5
|
Health Risk |
Pathogenic/Likely pathogenic |
Factor V deficiency, Thrombophilia due to activated protein C resistance |
| RS1571578995 |
F5
|
Health Risk |
Likely pathogenic |
Factor V deficiency, Factor V deficiency |
| RS1571581722 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor V deficiency, Congenital factor V deficiency |
| RS1571587012 |
PRG4
|
Health Risk |
Pathogenic |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
| RS1571588257 |
CD46
|
Health Risk |
Pathogenic |
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly, Atypical hemolytic-uremic syndrome |
| RS1571596976 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS1571599902 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS1571600045 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS1571600860 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 1, primary |
| RS1571601267 |
ASPM
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly 5, primary |
| RS1571602542 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS1571602991 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS1571603072 |
DDX59
|
Health Risk |
Likely pathogenic |
Orofaciodigital syndrome V, Orofaciodigital syndrome V |
| RS1571608729 |
TNNT2
|
Health Risk |
Likely pathogenic |
— |
| RS1571616755 |
CD46
|
Health Risk |
Likely pathogenic |
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly, Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly |
| RS1571616951 |
ASPM
|
Health Risk |
Likely pathogenic |
— |
| RS1571617647 |
CD46
|
Health Risk |
Pathogenic |
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly, Atypical hemolytic-uremic syndrome |
| RS1571623023 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1571626731 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1571627006 |
TNNT2
|
Health Risk |
Likely pathogenic |
Primary familial dilated cardiomyopathy, Primary familial dilated cardiomyopathy |
| RS1571627587 |
TNNT2
|
Health Risk |
Pathogenic |
Primary familial hypertrophic cardiomyopathy, Primary familial hypertrophic cardiomyopathy |
| RS1571630284 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS1571636501 |
KCND3
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 19/22, Spinocerebellar ataxia type 19/22 |
| RS1571636508 |
KCND3
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 19/22, Spinocerebellar ataxia type 19/22 |
| RS1571649028 |
DOCK7
|
Health Risk |
Likely pathogenic |
— |
| RS1571652012 |
REN
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial juvenile hyperuricemic nephropathy type 2, Renal tubular dysgenesis of genetic origin |
| RS1571655768 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Muscle eye brain disease, Muscle eye brain disease |
| RS1571657777 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1571657875 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1571659306 |
POMGNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 |
| RS1571668556 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinal dystrophy |
| RS1571672866 |
POMGNT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1571681377 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1571685736 |
NTRK1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, Hereditary insensitivity to pain with anhidrosis |
| RS1571685765 |
NTRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease |
| RS1571686349 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2, Usher syndrome type 2 |
| RS1571689751 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Inborn genetic diseases |
| RS1571690112 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS1571695851 |
NTRK1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Hereditary insensitivity to pain with anhidrosis |
| RS1571696060 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS1571699664 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS1571699945 |
NTRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Hereditary insensitivity to pain with anhidrosis |
| RS1571701069 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2, Usher syndrome type 2A |
| RS1571701072 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1571701243 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1571702193 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1571703770 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1571703801 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa |
| RS1571706279 |
CENPF
|
Health Risk |
Likely pathogenic |
— |
| RS1571707321 |
CENPF
|
Health Risk |
Likely pathogenic |
Stromme syndrome, Stromme syndrome |
| RS1571715796 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1571735403 |
TOR1AIP1
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2Y, Autosomal recessive limb-girdle muscular dystrophy type 2Y |
| RS1571762632 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2, Usher syndrome type 2 |
| RS1571774019 |
USH2A
|
Health Risk |
Pathogenic |
USH2A-related disorder, USH2A-related disorder |